Earth Life Sciences Inc.
CLTS
$0.00
$0.000.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | -- | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 600.00 | 600.00 | 600.00 | 600.00 | 1.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 600.00 | 600.00 | 600.00 | 600.00 | 1.00K |
|
|
|||||
| Total Current Assets | 600.00 | 600.00 | 600.00 | 600.00 | 1.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.43M | 4.43M | 4.43M | 4.43M | 176.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.43M | 4.43M | 4.43M | 4.43M | 177.00K |
|
|
|||||
| Total Accounts Payable | 143.10K | 125.60K | 109.40K | 78.70K | 67.10K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 267.70K | 264.40K | 299.20K | 294.20K | 307.70K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 410.80K | 390.00K | 408.60K | 372.80K | 374.70K |
|
|
|||||
| Total Current Liabilities | 410.80K | 390.00K | 408.60K | 372.80K | 374.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 267.70K | 264.40K | 299.20K | 294.20K | 307.70K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 410.80K | 390.00K | 408.60K | 372.80K | 374.70K |
|
|
|||||
| Common Stock & APIC | 22.97M | 22.97M | 22.63M | 22.63M | 18.36M |
| Retained Earnings | -19.08M | -19.06M | -18.74M | -18.71M | -18.69M |
| Treasury Stock & Other | 131.90K | 131.90K | 131.90K | 131.90K | 131.90K |
| Total Common Equity | 4.02M | 4.04M | 4.02M | 4.05M | -197.70K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.02M | 4.04M | 4.02M | 4.05M | -197.70K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.02M | 4.04M | 4.02M | 4.05M | -197.70K |
|
|
|||||
